Human Molecular Genetics, 2002, Vol. 11, No. 19 2297-2307
© 2002 Oxford University Press
Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells
1Institut de Génétique et de Biologie Moléculaire et Cellulaire, CNRS/INSERM/ULP, 1 rue Laurent Fries, BP 163, 67404 Illkirch Cedex, CU de Strasbourg, France, 2Faculté de Médecine Pitié-Salpêtrière, CNRS UMR 7000, Université Paris 6, 75634 Paris Cedex, France and 3Institut Fédératif de Recherche en Immunologie Cellulaire et Moléculaire, INSERM, Unité 326, Hôpital Purpan, 31059 Toulouse Cedex, France
Received May 20, 2002; Accepted July 11, 2002
The myotubularin-related 1 (MTMR1) gene belongs to a highly conserved family of eucaryotic phosphatases, with at least 11 members in humans. The founder member of this gene family, MTM1, is mutated in X-linked myotubular myopathy, a severe congenital disorder that affects skeletal muscle, and codes for myotubularin, a specific phosphatidylinositol 3-phosphate [PI(3)P] phosphatase. MTM1 and MTMR1 are adjacent on the X chromosome, and the corresponding proteins share 59% sequence identity. In the present study, we investigated the putative role of MTMR1 in myogenesis by analysing its expression pattern in muscle cells during differentiation and in skeletal muscle throughout development. We have identified three novel coding exons in the MTMR1 intron 2 that are conserved between mouse and human, are alternatively spliced, and give rise to six mRNA isoforms. One of the transcripts is muscle-specific and is induced during myogenesis both in vitro and in vivo, and represents the major isoform in adult skeletal muscle. We show that the two main MTMR1 protein muscular isoforms, like myotubularin, efficiently dephosphorylate PI(3)P in vitro. We have also analysed whether MTMR1 alternative splicing is affected in skeletal muscle cells derived from patients with congenital myotonic dystrophy (cDM1), in which mRNA splicing disturbances of specific genes are thought to constitute an important pathogenic mechanism. We found a striking reduction in the level of the muscle-specific isoform and the appearance of an abnormal MTMR1 transcript in differentiated cDM1 muscle cells in culture and in skeletal muscle from cDM1 patients. Our results suggest that MTMR1 plays a role in muscle formation and represents a novel target for abnormal mRNA splicing in myotonic dystrophy.
* To whom correspondence should be addressed. Tel: +33 388653244; Fax: +33 388653246; Email: mtm{at}titus.u-strasbg.fr
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
S.-i. Hino, S. Kondo, H. Sekiya, A. Saito, S. Kanemoto, T. Murakami, K. Chihara, Y. Aoki, M. Nakamori, M. P. Takahashi, et al. Molecular mechanisms responsible for aberrant splicing of SERCA1 in myotonic dystrophy type 1 Hum. Mol. Genet., December 1, 2007; 16(23): 2834 - 2843. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Osborne, S. Welle, S. L. Venance, C. A. Thornton, and R. Tawil Expression profile of FSHD supports a link between retinal vasculopathy and muscular dystrophy Neurology, February 20, 2007; 68(8): 569 - 577. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. L. Boutz, G. Chawla, P. Stoilov, and D. L. Black MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development Genes & Dev., January 1, 2007; 21(1): 71 - 84. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. J. Osborne and C. A. Thornton RNA-dominant diseases Hum. Mol. Genet., October 15, 2006; 15(suppl_2): R162 - R169. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. L. Robinson and J. E. Dixon The Phosphoinositide-3-phosphatase MTMR2 Associates with MTMR13, a Membrane-associated Pseudophosphatase Also Mutated in Type 4B Charcot-Marie-Tooth Disease J. Biol. Chem., September 9, 2005; 280(36): 31699 - 31707. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kimura, M. Nakamori, J. D. Lueck, P. Pouliquin, F. Aoike, H. Fujimura, R. T. Dirksen, M. P. Takahashi, A. F. Dulhunty, and S. Sakoda Altered mRNA splicing of the skeletal muscle ryanodine receptor and sarcoplasmic/endoplasmic reticulum Ca2+-ATPase in myotonic dystrophy type 1 Hum. Mol. Genet., August 1, 2005; 14(15): 2189 - 2200. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. N. Ladd, G. Taffet, C. Hartley, D. L. Kearney, and T. A. Cooper Cardiac Tissue-Specific Repression of CELF Activity Disrupts Alternative Splicing and Causes Cardiomyopathy Mol. Cell. Biol., July 15, 2005; 25(14): 6267 - 6278. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Ho, R. S. Savkur, M. G. Poulos, M. A. Mancini, M. S. Swanson, and T. A. Cooper Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy J. Cell Sci., July 1, 2005; 118(13): 2923 - 2933. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. H. Ho, D. Bundman, D. L. Armstrong, and T. A. Cooper Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy Hum. Mol. Genet., June 1, 2005; 14(11): 1539 - 1547. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Faustino and T. A. Cooper Identification of Putative New Splicing Targets for ETR-3 Using Sequences Identified by Systematic Evolution of Ligands by Exponential Enrichment Mol. Cell. Biol., February 1, 2005; 25(3): 879 - 887. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. L. Ber, M. Martinez, D. Campion, A. Laquerriere, C. Betard, G. Bassez, C. Girard, P. Saugier-Veber, G. Raux, N. Sergeant, et al. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24 Brain, September 1, 2004; 127(9): 1979 - 1992. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kino, D. Mori, Y. Oma, Y. Takeshita, N. Sasagawa, and S. Ishiura Muscleblind protein, MBNL1/EXP, binds specifically to CHHG repeats Hum. Mol. Genet., March 1, 2004; 13(5): 495 - 507. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tronchere, J. Laporte, C. Pendaries, C. Chaussade, L. Liaubet, L. Pirola, J.-L. Mandel, and B. Payrastre Production of Phosphatidylinositol 5-Phosphate by the Phosphoinositide 3-Phosphatase Myotubularin in Mammalian Cells J. Biol. Chem., February 20, 2004; 279(8): 7304 - 7312. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A. Rudge, D. M. Anderson, and S. D. Emr Vacuole Size Control: Regulation of PtdIns(3,5)P2 Levels by the Vacuole-associated Vac14-Fig4 Complex, a PtdIns(3,5)P2-specific Phosphatase Mol. Biol. Cell, January 1, 2004; 15(1): 24 - 36. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Chaussade, L. Pirola, S. Bonnafous, F. Blondeau, S. Brenz-Verca, H. Tronchere, F. Portis, S. Rusconi, B. Payrastre, J. Laporte, et al. Expression of Myotubularin by an Adenoviral Vector Demonstrates Its Function as a Phosphatidylinositol 3-Phosphate [PtdIns(3)P] Phosphatase in Muscle Cell Lines: Involvement of PtdIns(3)P in Insulin-Stimulated Glucose Transport Mol. Endocrinol., December 1, 2003; 17(12): 2448 - 2460. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Laporte, F. Bedez, A. Bolino, and J.-L. Mandel Myotubularins, a large disease-associated family of cooperating catalytically active and inactive phosphoinositides phosphatases Hum. Mol. Genet., October 15, 2003; 12(90002): R285 - 292. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Jasinska, G. Michlewski, M. de Mezer, K. Sobczak, P. Kozlowski, M. Napierala, and W. J. Krzyzosiak Structures of trinucleotide repeats in human transcripts and their functional implications Nucleic Acids Res., October 1, 2003; 31(19): 5463 - 5468. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Sobczak, M. de Mezer, G. Michlewski, J. Krol, and W. J. Krzyzosiak RNA structure of trinucleotide repeats associated with human neurological diseases Nucleic Acids Res., October 1, 2003; 31(19): 5469 - 5482. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. A. Faustino and T. A. Cooper Pre-mRNA splicing and human disease Genes & Dev., February 15, 2003; 17(4): 419 - 437. [Full Text] [PDF] |
||||









